Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Use-Results Survey of Kyprolis in Relapsed or Refractory Multiple Myeloma (All-Case Surveillance)
jRCT1080224009Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2018
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carfilzomib in multiple myeloma (MM), sponsored by Ono Pharmaceutical. Started Jul 2018; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on jRCT1080224009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224009.